In contrast to 5-methylcytosine (5-mC), which has been studied extensively [1] [2] [3] , little is known about 5-hydroxymethylcytosine (5-hmC), a recently identified epigenetic modification present in substantial amounts in certain mammalian cell types 4, 5 . Here we present a method for determining the genomewide distribution of 5-hmC. We use the T4 bacteriophage b-glucosyltransferase to transfer an engineered glucose moiety containing an azide group onto the hydroxyl group of 5-hmC. The azide group can be chemically modified with biotin for detection, affinity enrichment and sequencing of 5-hmC-containing DNA fragments in mammalian genomes. Using this method, we demonstrate that 5-hmC is present in human cell lines beyond those previously recognized 4 . We also find a gene expression level-dependent enrichment of intragenic 5-hmC in mouse cerebellum and an age-dependent acquisition of this modification in specific gene bodies linked to neurodegenerative disorders.
l e t t e r s
In contrast to 5-methylcytosine (5-mC), which has been studied extensively [1] [2] [3] , little is known about 5-hydroxymethylcytosine (5-hmC), a recently identified epigenetic modification present in substantial amounts in certain mammalian cell types 4, 5 .
Here we present a method for determining the genomewide distribution of 5-hmC. We use the T4 bacteriophage b-glucosyltransferase to transfer an engineered glucose moiety containing an azide group onto the hydroxyl group of 5-hmC. The azide group can be chemically modified with biotin for detection, affinity enrichment and sequencing of 5-hmC-containing DNA fragments in mammalian genomes. Using this method, we demonstrate that 5-hmC is present in human cell lines beyond those previously recognized 4 . We also find a gene expression level-dependent enrichment of intragenic 5-hmC in mouse cerebellum and an age-dependent acquisition of this modification in specific gene bodies linked to neurodegenerative disorders.
Parallel to the discovery of 5-hmC in mammalian genomes 4, 5 , Tet proteins were shown to use dioxygen to oxidize 5-mC to 5-hmC in mammalian DNA 5 . Tet proteins are a group of iron(II)/α-ketoglutaratedependent dioxygenases similar to the AlkB family proteins and hypoxiainducible factor (HIF) prolyl-hydroxylases 6, 7 . As Tet1 and Tet2 appear to affect embryonic stem (ES) cell maintenance and normal myelopoiesis, respectively 8, 9 , these findings fostered speculation that this 5-hmC modification might also be an important epigenetic modification 10 .
To elucidate the biology of 5-hmC, the first step is to identify the locations of 5-hmC within genomic DNA, but so far it has remained challenging to distinguish 5-hmC from 5-mC and to enrich 5-hmCcontaining genomic DNA fragments.
Widely used methods to probe 5-mC, such as bisulfite sequencing and methylation-sensitive restriction digestion, cannot discriminate between 5-hmC and 5-mC 11, 12 . Anti-5-hmC antibodies have only recently become commercially available. However, attempts to use the antibodies to immuno-enrich 5-hmC-containing genomic DNA from complex genomes for sequencing have yet to be successful 8 .
A single-molecule, real-time sequencing technology has been applied to distinguish between cytosine, 5-mC and 5-hmC, but further improvements are necessary to affinity-enrich 5-hmC-containing DNA and to achieve base-resolution sequencing 13 .
Here we present a chemical tagging technology to address both challenges. It has been shown that 5-hmC is present in the genome of the T-even bacteriophages. A viral enzyme, β-glucosyltransferase (β-GT), can catalyze the transfer of a glucose moiety from uridine diphosphoglucose (UDP-Glu) to the hydroxyl group of 5-hmC, yielding β-glucosyl-5-hydroxymethyl-cytosine (5-gmC) in duplex DNA 14, 15 (Fig. 1a) . We took advantage of this enzymatic process and used β-GT to transfer a chemically modified glucose, 6-N 3 -glucose, onto 5-hmC for selective bio-orthogonal labeling of 5-hmC in genomic DNA (Fig. 1b) . With an azide group present, a biotin tag or any other tag can be installed using Huisgen cycloaddition (click) chemistry for a variety of enrichment, detection and sequencing applications [16] [17] [18] .
We used the biotin tag for high-affinity capture and/or enrichment of 5-hmC-containing DNA for sensitive detection and deep sequencing to reveal genomic locations of 5-hmC (Fig. 1b) . The covalent chemical labeling coupled with biotin-based affinity purification provides considerable advantages over noncovalent, antibody-based immunoprecipitation as it ensures accurate and comprehensive capture of 5-hmC-containing DNA fragments, while still providing high selectivity.
We chemically synthesized UDP-6-N 3 -Glu ( Supplementary Fig. 1 and Supplementary Methods) and attempted the glycosylation reaction of an 11-mer duplex DNA containing a 5-hmC modification as a model system (Fig. 2) . Wild-type β-GT worked efficiently using UDP-6-N 3 -Glu as the co-factor, showing only a sixfold decrease of the reaction rate compared to the native co-factor UDP-Glu (Supplementary Fig. 2 ). The 6-N 3 -glucose transfer reaction finished within 5 min with as low as 1% enzyme concentration. The identity of the resulting β-6-azideglucosyl-5-hydroxymethyl-cytosine (N 3 -5-gmC) of the 11-mer DNA was confirmed by matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) analysis (Fig. 2) . One can readily couple N 3 -5-gmC with dibenzocyclooctyne-modified biotin (compound 1) by copper-free selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine l e t t e r s click chemistry to introduce a biotin group (Fig. 2) 19, 20 . Again, the identity of the 11-mer DNA with the biotin-N 3 -5-gmC label was confirmed by MALDI-TOF analysis (Fig. 2) . High-performance liquid chromatography (HPLC) analysis indicated that the click chemistry is high yielding (~90%) (Supplementary Fig. 3 ). High-resolution mass spectroscopy (HRMS) analysis of the corresponding HPLC hydrolysates further verified that biotin-N 3 -5-gmC was formed ( Supplementary Fig. 4) .
The properties of 5-hmC in duplex DNA are quite similar to those of 5-mC in terms of its sensitivity toward enzymatic reactions such as restriction enzyme digestion and polymerization [13] [14] [15] . In an attempt to develop a method to differentiate these two bases in DNA, primer extension with a biotin-N 3 -5-gmC-modified DNA template was tested. Addition of streptavidin tetramer (binds biotin tightly) completely stops replication by Taq polymerase specifically at the modified position as well as one base before the modified position (Supplementary Fig. 5 ). Therefore, this method has the potential to provide singlebase resolution of the location of 5-hmC in DNA loci of interest.
Next, we performed selective labeling of 5-hmC in genomic DNA from various cell lines and animal tissues. Genomic DNA from various sources was sonicated into small fragments (~100-500 base pairs), treated with β-GT in the presence of UDP-6-N 3 -Glu or regular UDP-Glu (control group) to yield N 3 -5-gmC or 5-gmC modifications and finally labeled with cyclooctyne-biotin (1) to install biotin. Because each step is efficient and bio-orthogonal, this protocol ensures selective labeling of most 5-hmC in genomic DNA. The presence of biotin-N 3 -5-gmC allows affinity enrichment of this modification and accurate quantification of the amount of 5-hmC in a genome using avidin-horseradish peroxidase (HRP).
We determined the total amount of 5-hmC in mouse cerebellum at different stages of development (Fig. 3a,b) . The control group showed almost no signal, demonstrating the high selectivity of this method. The amount of 5-hmC depends on the developmental stage of the mouse cerebellum (Fig. 3b) . A gradual increase from postnatal day 7 (P7, 0.1% of total nucleotides in the genome) to adult stage (0.4% of total nucleotides) was observed 21 , which was further confirmed using antibody against 5-hmC through a dot-blot assay (Supplementary Fig. 6a ). Our observation suggests that 5-hmC might play an important role in brain development. The 5-hmC level of mouse embryonic stem cells (mESC) was determined to be comparable to results reported previously (~0.05% of total nucleotides) (Fig. 3c,d ) 5 . In addition, the amount of 5-hmC in mouse adult neural stem cells (aNSC) was tested, which proved comparable to that of mESC (~0.04% of total nucleotides) (Fig. 3c,d ). The hydroxyl group of 5-hmC in duplex DNA can be glucosylated by β-GT to form β-glucosyl-5-hydroxymethylcytosine (5-gmC) using UDP-Glu as a cofactor. (b) An azide group can be installed onto 5-hmC using chemically modified UDP-Glu (UDP-6-N 3 -Glu), which in turn can be labeled with a biotin moiety using click chemistry for subsequent detection, affinity purification and sequencing. 
t t e r s
We also tested human cell lines (Fig. 3c,d) . Notably, the presence of 5-hmC was detected in HeLa and HEK293FT cell lines, although in much lower abundance (~0.01% of total nucleotides) ( Fig. 3d) than in other cells or tissues that have been previously reported to contain 5-hmC (previous studies did not show the presence of 5-hmC in HeLa cells due to the limited sensitivity of the methods employed 4 ). These results suggest that this modification may be more widespread than previously anticipated. By contrast, no 5-hmC signal was detected in wild-type Drosophila melanogaster, consistent with a lack of DNA methylation in this organism 22 .
To further validate the utility of the method for biological samples we confirmed the presence of 5-hmC in the genomic DNA from HeLa cells. A monomeric avidin column was used to pull down the biotin-N 3 -5-gmC-containing DNA after genomic DNA labeling. These enriched DNA fragments were digested into single nucleotides, purified by HPLC and subjected to HRMS analysis. To our satisfaction, we obtained HRMS as well as MS/MS spectra of biotin-N 3 -5-gmC identical to the standard from synthetic DNA ( Supplementary Fig. 4 and Fig. 6b,c) . In addition, two 60-mer double-stranded (ds)DNAs, one with a single 5-hmC in its sequence and the other without the modification, were prepared. We spiked equal amounts of both samples into mouse genomic DNA and performed labeling and subsequent affinity purification of the biotinylated DNA. The pull-down sample was subjected to deep sequencing, and the result showed that the 5-hmC-containing DNA was >25-fold higher than the control sample ( Supplementary Fig. 7) .
Next, we performed chemical labeling of genomic DNA from mouse cerebellum, subjecting the enriched fragments to deep sequencing such that 5-hmC-containing genomic regions could be identified. Initially, we compared male and female adult mice (2.5 months old), sequencing multiple independent biological samples and multiple libraries prepared from the same genomic DNA. Genome-scale density profiles are nearly identical between male and female and are clearly distinguishable from both input genomic DNA and control DNA labeled with regular glucose (no biotin) (Fig. 4a) . Peak identification revealed a total of 39,011 highconfidence regions enriched consistently with 5-hmC in both male and female ( Fig. 4a and Supplementary Table 1 ). All of the 13 selected, enriched regions were subsequently successfully verified in both adult female and male cerebellum by quantitative PCR (qPCR), whereas multiple control regions did not display enrichment ( Supplementary Fig. 8 ).
DNA methylation is widespread in mammalian genomes, with the exception of most transcription start sites (TSS) [23] [24] [25] . Previous studies have mostly assessed DNA methylation by bisulfite sequencing and methylation-sensitive restriction digests. It has since been appreciated that neither of these methods adequately distinguishes 5-mC from 5-hmC 11, 12 . To determine the genome-wide distribution of 5-hmC, we generated metagene 5-hmC read density profiles for RefSeq transcripts. Normalized 5-hmC read densities differ by an average of 2.10 ± 0.04% (mean ± s.e.m.) in adult male and female cerebellum samples, indicating that the profiles are accurate and reproducible. We observed enrichment of 5-hmC in gene bodies as well as in proximal upstream and downstream regions relative to TSS, transcription termination sites (TTS) and distal regions (Fig. 4b) . This is in contrast to previously generated methyl-binding domain-sequencing (MBD-Seq) 26 , as well as our own methylated DNA immunoprecipitation sequencing (MeDIP-Seq) from mouse cerebellum genomic DNA, in which the majority (~80%) of 5-mC-enriched DNA sequences were derived from satellite and/or repeat regions ( Supplementary  Fig. 9 ). Further analyses also reveal that both intragenic and proximal enrichment of 5-hmC is associated with more highly expressed genes, consistent with a role for 5-hmC in maintaining and/or promoting gene expression (Fig. 4b) . Proximal enrichment of 5-hmC ~875 bp upstream of TSSs and ~160-200 bp downstream of the annotated TTSs further suggests a role for these regions in the regulation of gene expression through 5-hmC.
Quantification of bulk 5-hmC in the cerebellum of P7 and adult mice indicates genomic acquisition of 5-hmC during cerebellum maturation (Fig. 3a) . We further explored this phenomenon by sequencing 5-hmC-enriched DNA from P7 cerebellum and compared these sequences to those derived from adult mice. Metagene profiles at RefSeq transcripts confirmed an increase in proximal and intragenic 5-hmC in adult relative to P7 cerebellum, although there was little to no difference and minimal enrichment over input genomic DNA in distal regions (Fig. 4c and Supplementary Table 2) . Peak identification using P7 as background identified a total of 20,092 enriched regions that showed significant differences between P7 and adult tissues. Of those, 15,388 (76.6%) occurred within 5,425 genes acquiring intragenic 5-hmC in adult females ( Supplementary Fig. 10 and Supplementary Table 3) .
Gene ontology pathway analysis of the 5,425 genes acquiring 5-hmC during aging identified significant enrichment of pathways associated with age-related neurodegenerative disorders as well as angiogenesis and hypoxia response ( Fig. 4d and Supplementary Table 4) . This is of particular interest given that all these pathways have been linked to oxidation stress response and that the conversion of 5-mC to 5-hmC requires dioxygen 5 . Furthermore, an assessment of the gene l e t t e r s list revealed that 15/23 genes previously identified as causing ataxia and disorders of Purkinje cell degeneration in mouse and human acquired intragenic 5-hmC in adult mice ( Supplementary Fig. 11 and Supplementary Table 5 ) 27 . Together, these observations suggest that 5-hmC may play a role in age-related neurodegeneration. Recently, β-GT was used to transfer a radiolabeled glucose for 5-hmC quantification 28 . (Our paper was under review when ref. 28 was published.) A major advantage of our technology is its ability to selectively label 5-hmC in genomic DNA with any tag. With a biotin tag attached to 5-hmC, DNA fragments containing 5-hmC can be affinity purified for deep sequencing to reveal distribution and/or location of 5-hmC in mammalian genomes. Because biotin is covalently linked to 5-hmC and biotin-avidin/streptavidin interaction is strong and highly specific, this technology promises high robustness as compared to potential anti-5-hmC, antibody-based, immune-purification methods 8 . Other fluorescent or affinity tags may be readily installed using the same approach for various other applications. For instance, imaging of 5-hmC in fixed cells or even live cells (if labeling can be performed in one step with a mutant enzyme) may be achieved with a fluorescent tag. In addition, the chemical labeling of 5-hmC with a bulky group could interfere with restriction enzyme digestion or ligation, which may be used to detect 5-hmC in specific genome regions. The attachment of biotin or other tags to 5-hmC also dramatically enhances the sensitivity and simplicity of the 5-hmC detection and/or quantification in various biological samples 28 . The detection limit of this method can reach ~0.004% (Fig. 3d) and the method can be readily applied to study a large number of biological samples.
With the technology presented here, we observed the developmental stage-dependent increase of 5-hmC in mouse cerebellum. Compared to postnatal day 7 at a time of massive cell proliferation in the mouse cerebellum, adult cerebellum has a significantly increased level of 5-hmC, suggesting that 5-hmC might be involved in neuronal development and maturation. Indeed, we also observed an increase of 5-hmC in aNSCs upon differentiation (unpublished data).
This technology enables us to selectively capture 5-hmC-enriched regions in the cerebellums from both P7 and adult mice, and determine the genome-wide distribution of 5-hmC by deep sequencing. Our analyses revealed general features of 5-hmC in mouse cerebellum. First, 5-hmC was enriched specifically in gene bodies as well as defined gene proximal regions relative to more distal regions. This differs from the distribution of 5-mC, where DNA methylation has been found both within gene bodies as well as in more distal regions [23] [24] [25] 29 . Second, the enrichment of 5-hmC is higher in gene bodies that are more highly expressed, suggesting a potential role for 5-hmC in activating and/or maintaining gene expression. It is possible that conversion of 5-mC to 5-hmC is a pathway to offset the gene repression effect of 5-mC during this process without going through demethylation 30 . Third, we observed an enrichment of 5-hmC in genes linked to hypoxia and angiogenesis. The oxidation of 5-mC to 5-hmC by Tet proteins requires dioxygen 5, 8 . A wellknown oxygen sensor in mammalian systems that are involved in hypoxia and angiogenesis is the HIF protein, which belongs to the same mononuclear iron-containing dioxygenase superfamily as the active domain of the Tet proteins 7 . It is tempting to speculate that l e t t e r s oxidation of 5-mC to 5-hmC by Tet proteins may constitute another oxygen-sensing and regulation pathway in mammalian cells. Lastly, the association of 5-hmC with genes that have been implicated in neurodegenerative disorders suggests that this base modification could potentially contribute to the pathogenesis of human neurological disorders. Should a connection between 5-hmC levels and human disease be established, the affinity purification approach shown in the current work could be used to purify and/or enrich 5-hmC-containing DNA fragments as a simple and sensitive method for disease prognosis and diagnosis. In summary, we have developed an efficient and selective method to label and capture 5-hmC from genomic DNA. We have demonstrated the feasibility of using this approach to determine the genome-wide distribution of 5-hmC. Future application of this technology would enable us to understand the role(s) of the 5-hmC modification at molecular, cellular and physiological levels.
MeTHoDs
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturebiotechnology/.
oNLINe MeTHoDs Preparation of genomic DNA. All animal procedures were performed according to protocols approved by Emory University Institutional Animal Care and Use Committee. Genomic DNA from tissues and cell lines was purified using Wizard genomic DNA purification kit (Promega) with additional Proteinase K treatment and rehydrated in 10 mM Tris (pH 7.9). Genomic DNA samples were further sonicated in Eppendorf tubes into 100-500 bp by Misonix sonicator 3000 (using microtip, three pulses of 30 s each with 2 min of rest and a power output level of 2) or Bioruptor UCD-200 sonicator (Diagenode, Sparta). (The output selector switch was set on High (H), and sonication interval was 30 s with 30 cycles of sonication performed. In addition, samples were resuspended and centrifuged briefly every five cycles to keep the constancy of DNA shearing.) Cerebellums from P7 and 10-week-old C57BL/6 were used. Mouse feeder-free E14Tg2A ES cells (mESC) were cultured as reported 31 . Adult neural stem cells (aNSCs) were isolated and cultured as described previously 32 .
Construction, expression and purification of wild-type b-GT. β-GT was cloned from the extract of T4 bacteriophage (American Type Culture Collection) into the target vector pMCSG19 by the ligation independent cloning method 33 . The resulting plasmid was transformed into BL21 star (DE3)-competent cells containing pRK1037 (Science Reagents) by heat shock. Positive colonies were selected with 150 g/ml ampicillin and 30 g/ml kanamycin. One liter of cells was grown at 37 °C from a 1:100 dilution of an overnight culture. The cells were induced with 1 mM of isopropyl-β-dthiogalactoside when OD 600 reached 0.6-0.8. After overnight growth at 16 °C with shaking, the cells were collected by centrifugation, suspended in 30 ml Ni-NTA buffer A (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 30 mM imidazole and 10 mM β-mercaptoethanol) with protease inhibitor phenylmethylsulfonyl fluoride. After loading to a Ni-NTA column, proteins were eluted with a 0-100% gradient of Ni-NTA buffer B (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 400 mM imidazole and 10 mM β-mercaptoethanol). β-GT-containing fractions were further purified by MonoS (GE Healthcare) (buffer A: 10 mM Tris-HCl, pH 7.5; buffer B: 10 mM Tris-HCl, pH 7.5 and 1 M NaCl). Finally, the collected protein fractions were loaded onto a Superdex 200 (GE Healthcare) gel-filtration column equilibrated with 50 mM Tris-HCl (pH 7.5), 20 mM MgCl 2 and 10 mM β-ME. The purity of the purified protein was determined by SDS-PAGE to be >95%. β-GT was concentrated to 45 µM and stored frozen at −80 °C with an addition of 30% glycerol.
Oligonucleotide synthesis. Oligonucleotides containing 5-hmC were prepared using Applied Biosystems 392 DNA synthesizer. 5-HydroxymethyldC-CE phosphoramidite (Glen Research) was used to incorporate 5-hmC at the desired position during solid-phase synthesis, followed by postsynthetic deprotection by treatment with 30% ammonium hydroxide first and then 25-30% wt/wt solution of sodium methoxide in methanol (Alfa Aesar) overnight at 25 °C. The 11-mer DNA was purified by reversed-phase HPLC and confirmed by MALDI-TOF. Other DNA was purified by denaturing PAGE. Concentrations of the oligonucleotides were estimated by UV at 260 nm. Duplexes were prepared by combining equimolar portions of the each strand in annealing buffer (10 mM Tris, pH 7.5, 100 mM NaCl), heating for 10 min at 95 °C followed by slow cooling overnight.
5-hmC labeling reaction and click chemistry.
The 5-hmC labeling reactions were performed in a 100-µl solution containing 50 mM HEPES buffer (pH 7.9), 25 mM MgCl 2 , 300 ng/µl sonicated genomic DNA (100-500 bp), 250 µM UDP-6-N 3 -Glu, and 2.25 µM wild-type βGT. The reactions were incubated for 1 h at 37 °C. After the reaction, the DNA substrates were purified by Qiagen DNA purification kit or by phenol-chloroform precipitation and reconstituted in H 2 O. The click chemistry was performed with addition of 150 µM dibenzocyclooctyne modified biotin (compound 1) into the DNA solution, and the reaction mixture was incubated for 2 h at 37 °C. The DNA samples were then purified by Qiagen DNA purification kit, which were ready for further applications. 5-hmC (biotin-N 3 -5-gmC) . Genomic DNAs used for deep sequencing were purified/enriched by Pierce Monomeric Avidin Kit (Thermo) twice following manufacturer's recommendations. After elution, the biotin-N 3 -5-gmC containing DNA was concentrated by 10 K Amicon Ultra-0.5 ml Centrifugal Filters (Millipore) and purified by Qiagen DNA purification kit. Starting with 30 µg total genomic DNA, we can obtain 100-300 ng enriched DNA samples following the labeling and pull-down protocol described here. The deep sequencing experiment can be performed with as low as 10 ng DNA sample.
Affinity enrichment of the biotinylated
Primer extension assay. Reverse primer (14-mer, 5′-AAGCTTCTGGAGTG-3′, purchased from Eurofins MWG Operon and PAGE purified) was end-labeled with T4 polynucleotide kinase (T4 PNK) (New England Biolabs) and 15 µCi of [γ-32 P]-ATP (PerkinElmer) for 0.5 h at 37 °C, and then purified by Bio-Spin 6 column (Bio-Rad). For primer extension assay, REDTaq DNA polymerase (Sigma) was used. We first mixed 0.2 pmol template and 0.25 pmol γ-32 Plabeled primers with dNTP in the polymerase reaction buffer without adding polymerase. The mixture was heated at 65 °C for 2 min and allowed to cool slowly for 30 min. Streptavdin in PBS was then added if needed and allowed to mix at 25 °C for 5 min. REDTaq DNA polymerase was then added (final volumn 20 µl) and the extension reaction was run at 72 °C for 1 min. The reaction was quenched by 2× stop solution (98% formamide, 10 mM EDTA, 0.1% xylene cyanol, 0.1% bromophenol blue) and loaded on to a 20% denaturing polyacrylamide gel (7 M urea). Sanger sequencing was performed using Sequenase DNA Sequencing Kit (USB) with 1 pmol template and 0.5 pmol [γ-32 P]-labeled primer. The results were visualized by autoradiography.
Large-scale HeLa 5-hmC pull-down. Twenty dishes (15 cm) of HeLa cells were harvested and resuspended at 20 ml of 10 mM Tris (pH 8.0), 10 mM EDTA. Sodium dodecyl sulfate (SDS) and Proteinase K were added to final concentrations of 0.5% and 200 µg/ml, respectively, and the solution was allowed to incubate at 55 °C for 2 h. After adding NaCl to a final concentration of 0.2 M, the sample was extracted twice with equal volumes of phenol/chloroform/isoamyl alcohol (25:24:1) and once with chloroform. Chloroform was evaporated by placing the tube in 55 °C water bath for 1 h with cap open. RNase A was then added to a final concentration of 25 µg/ml and the solution incubated for 1 h at 37 °C. DNA was then extracted once with phenol/ chloroform/isoamyl alcohol (25:24:1) and once with chloroform and precipitated with 1.5 volumes of ethanol. Genomic DNA was washed twice with 20 ml of 70% ethanol, dried and resuspended in 10 mM Tris (pH 7.9) at 37 °C. Genomic DNA was then sonicated by Bioruptor UCD-200 sonicator into 100-1,000 bp as noted before. The 5-hmC labeling reaction was carried out in a 4 ml solution containing 50 mM HEPES buffer (pH 7.9), 25 mM MgCl 2 , 550 ng/µl sonicated HeLa genomic DNA, 250 µM UDP-6-N 3 -Glu and 2.25 µM wild-type β-GT. The reaction was incubated for 1 h at 37 °C, purified by phenol-chloroform precipitation and reconstituted in 4 ml H 2 O. We added 20 µl of 30 mM dibenzocyclooctynemodified biotin (compound 1) and incubated the mixture for 2 h at 37 °C. The DNA sample was purified again by phenol-chloroform precipitation and then enriched for biotin-N 3 -5-gmC by monomeric avidin column as noted before. The pull-down DNA was concentrated and digested by nuclease P1 (Sigma), venom phosphodiesterase I (Type VI) (Sigma) and alkaline phosphatase (Sigma) according to published protocols 34 . The sample was purified by HPLC C18 reversed-phase column as noted in Supplementary Figure 3 . The peaks corresponding to the biotin-N 3 -5-gmC from synthetic DNA were collected, lyophilized and subjected to HRMS analysis. For HRMS analysis, lyophilized fractions were dissolved in 100 µl of 50% methanol and 5-20 µl samples were injected for LC-MS/MS analysis. The LC-MS/MS system is composed of an Agilent 1200 HPLC system and an Agilent 6520 QTOF system controlled by MassHunter Workstation Acquisition software (B.02.01 Build 2116). A reversed-phase C18 column (Kinetex C18, 50 mm × 2.1 mm, 1.7 µm, with 0.2 µm guard cartridge) flowing at 0.4 ml min −1 was used for online separation to avoid potential ion suppression. The gradient was from 98% solvent A (0.05% (vol/vol) acetic acid in MilliQ water), held for 0.5 min, to 100% solvent B (90% acetonitrile (vol/vol) with 0.05% acetic acid (vol/vol) in 4 min. MS and MS/MS data were acquired in extended dynamic range (1,700 m/z) mode, with post-column addition of reference mass solution for real time mass calibration. Dot-blot assays and quantification of genomic DNA containing 5-hmC. Labeled genomic DNA samples (biotin-N 3 -5-gmC, 40 ng for mouse cerebellum samples, 700 ng for other samples) were spotted on an Amersham Hybond-N + membrane (GE Healthcare). DNA was fixed to the membrane by Stratagene UV Stratalinker 2400 (auto-crosslink). The membrane was then blocked with 5% BSA and incubated with avidin-HRP (1:20,000) (Bio-Rad), which was visualized by enhanced chemiluminescence. Quantification was calculated using a working curve generated by 1-8 ng of 32 bp synthetic biotin-N 3 -5-gmC-containing DNA. Polyclonal antibody against 5-hmC (Active Motif) was also used for dot-blot assay (1:10,000 dilution).
5-hmC-enrichment test.
Two solutions of 60-mer dsDNA (see Supplementary  Fig. 7) were prepared as noted. Mouse DNA (30 µg) was spiked with 3 pg from each DNA solution. We did 5-hmC labeling and enrichment as noted. The pull-down DNA (10 ng) was end-repaired, adenylated, ligated to adapters (size selection 140-400 bp) and sequenced on an Illumina Genome Analyzer according to the manufacturer's recommendations for Illumina ChIP-Seq to identify spike enrichment.
Reads were mapped to the Mus musculus reference genome (NCBI37/ mm9), excluding sequences that were not finished or that have not be placed with certainty (i.e., exclusion of sequences contained in the chrUn_random. fa and chrN_radom.fa files provided by the UCSC genome browser) and appended to contain fasta sequences corresponding to the positive and negative spiked controls. Sequence alignment was accomplished using bwa 35 and default alignment settings.
Deep sequencing of mouse cerebellum genomic DNA. DNA libraries were generated following the Illumina protocol for "Preparing Samples for ChIP Sequencing of DNA" (Part# 111257047 Rev. A). 25 ng genomic DNA, 5-hmCcaptured DNA, or control captured DNA (in the absence of biotin) were used to initiate the protocol. In some instances < 25 ng DNA was eluted in the no-biotin control treatment. In these cases the entire amount of eluted DNA was used to initiate library preparation. DNA fragments ~150-300 bp were gel purified after the adaptor ligation step. PCR amplified DNA libraries were quantified on an Agilent 2100 Bioanalyzer and diluted to 6 pM for cluster generation and sequencing. 38-cycle single end sequencing was performed using Version 4 Cluster Generation and Sequencing Kits (Part #15002739 and #15005236 respectively) and Version 7.0 recipes. Image processing and sequence extraction were done using the standard Illumina Pipeline.
Sequence alignment and peak identification. FASTQ sequence files were aligned to Mus musculus reference genome (NCBI37/ mm9) using Bowtie 36 ( Supplementary Fig. 12 ). The--best alignment and reporting option was used for all conditions, corresponding to no more than 2 bp mismatches across each 38 bp read. 5-hmC peak identification was performed using nonduplicate reads with MACS 37 . Parameters were as follows: effective genome size = 2.72e+09; tag size = 38; band width = 100; model fold = 10; P value cutoff = 1.00e-05; ranges for calculating regional lambda are: peak_region, 1,000, 5,000, 10,000.
For identification of high-confidence peaks consistently detected in adult female and male samples, data from all lanes were merged per condition (5-hmC enriched, nonenriched genomic DNA input) for each sex and used in the analysis described above. Using a combined input genomic DNA sequence set (male input plus female input) as background, we observed 78.7% overlap in identified peaks between male and female samples. As a more stringent analysis, we also used sex-matched input genomic DNA as background/control samples for peak identification. A total of 91,751 peaks were identified in adult female cerebellum and a total of 240,147 peaks were identified in adult male cerebellum using these parameters; 39,011 peaks overlapped ≥1 bp between sexes and are reported as the set of high-confidence peaks consistently detected adult cerebellum (Supplementary Table 1) . Regions enriched for 5-hmC in adult cerebellum relative to P7 cerebellum were identified using a single lane of adult female 5-hmC reads as the treatment and the single lane of P7 reads as the background and/or control sample (Supplementary Table 2 ). A total of 20,092 regions were identified as enriched for 5-hmC in adult female cerebellum relative to P7 cerebellum. Of these, 15,388 (76.6%) were intragenic to 5,425 unique RefSeq transcripts. Genes acquiring 5-hmC during development (Supplementary Table 3 ) are those with peaks overlapping ≥1bp of a RefSeq gene.
Generation of metagene profiles and heatmaps. Metagene RefSeq transcript profiles were generated by first determining the distance between any given read and the closest TSS or TTS and then summing the number of 5′ends within 10 bp bins centered on either TSS or txEnds. Ten bp bins were then examined 5 kb upstream and 3 kb downstream to assess the level of 5-hmC in gene bodies relative to TSS and txEnds. The RefSeq reference file was obtained through the UCSC Genome Browser Tables (downloaded 05/ Read densities (Reads/10bp) were calculated for each individual lane of sequence listed in Supplementary Table 1 and then normalized per million reads of aligned sequence to generate a normalized read density. For samples sequenced on multiple lanes, normalized read densities were averaged. To generate the metagene profile for adult cerebellum we averaged normalized read densities from male and female. We observed excellent consistency in normalized read densities between both technical replicates (independent library preparation and sequencing the same library on multiple lanes) as well as between biological replicates (male and female adult samples). For genomic DNA input libraries from male and female samples normalized read densities differed by 3.41 ± 0.05% (mean ± s.e.m.). For 5-hmC libraries from male and female samples normalized read densities differed by 2.10 ± 0.04% (mean ± s.e.m.).
To assess 5-hmC in genes expressed at different levels, we obtained adult cerebellum gene expression data from the NCBI GEO sample GSM82974. Signal intensities were downloaded directly, divided into four bins of equal size, and converted into RefSeq mRNA IDs. We then mapped 5-hmC reads to the TSS and txEnds as described above. Heatmap representations of sequence densities were generated using Integrated Genomics Viewer tools and browser (IGV 1.4.2, http://www.broadinstitute.org/igv) with a window size (-w) of 25 and a read extend (-e) of 200.
